Dajeon, South Korea

Hyung-Sub Gwak

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Neopharm Co., Ltd.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung-Sub Gwak. Retrieved from https://idiyas.com/inventor/hyung-sub-gwak-zf2ipalw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyung-Sub Gwak: Innovator in Dermatological Therapeutics

Introduction

Hyung-Sub Gwak is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of dermatology through his innovative research and development of therapeutic agents.

Latest Patents

Hyung-Sub Gwak holds 1 patent related to ceramide derivatives. His patent, titled "Ceramide derivatives, method for preparing the same, and therapeutic agent for treating atopic dermatitis comprising the ceramide derivatives," discloses ceramide derivatives represented by specific formulas. The patent also outlines a method for preparing these derivatives and describes their use as active ingredients in a therapeutic agent for treating atopic dermatitis.

Career Highlights

Hyung-Sub Gwak is associated with Neopharm Co., Ltd., where he continues to advance his research in dermatological treatments. His work has the potential to improve the quality of life for individuals suffering from atopic dermatitis.

Collaborations

Some of his notable coworkers include Byeong-Deog Park and Jong-Kyung Youm, who contribute to the innovative environment at Neopharm Co., Ltd.

Conclusion

Hyung-Sub Gwak's contributions to the field of dermatology through his innovative patents highlight his role as a key inventor in developing effective treatments for skin conditions. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…